106
Participants
Start Date
February 1, 2022
Primary Completion Date
December 31, 2026
Study Completion Date
November 30, 2028
DNL593
Ascending single doses (for healthy participants) and multiple doses (for participants with FTD)
Placebo
Ascending single doses (for healthy participants) and multiple doses (for participants with FTD)
RECRUITING
Hospital Clinic de Barcelona, Barcelona
RECRUITING
Hospital of the University of Pennsylvania, Philadelphia
RECRUITING
Hospital Universitario de Donostia, Donostia / San Sebastian
RECRUITING
John Hopkins University, Baltimore
WITHDRAWN
Hospital Universitario La Paz, Madrid
RECRUITING
Hospital Universitario Virgen del Rocio, Seville
RECRUITING
University of California San Francisco, San Francisco
RECRUITING
University of Antwerp, Antwerp
RECRUITING
UZ Leuven, Leuven
RECRUITING
L2IP - Instituto de Pesquisas Clinicas LTDA, Brasília
WITHDRAWN
Hospital de Clinicas de Porto Alegre (HCPA) - PPDS, Porto Alegre
RECRUITING
Faculdade de Medicina Da Universidade de São Paulo, São Paulo
RECRUITING
Hospital Universitario San Ignacio, Bogotá
RECRUITING
Grupo de Neurosicencias de la Universidad de Antioquia, Medellín
NOT_YET_RECRUITING
Fakultni nemocnice v Motole, Prague
RECRUITING
CHU de Nantes, Nantes
RECRUITING
CHU Rouen, Rouen
RECRUITING
CHU Toulouse, Toulouse
RECRUITING
ASST degli Spedali Civili di Brescia, Brescia
RECRUITING
Azienda Ospedaliera Universitaria Careggi, Florence
RECRUITING
IRCCS Istituto Auxologico Italiano, Milan
RECRUITING
Azienda Ospedaliera Cardinale G Panico, Tricase
RECRUITING
Erasmus University Medical Center, Rotterdam
RECRUITING
Hospital de Braga, Braga
WITHDRAWN
Hospital Pedro Hispano, Matosinhos Municipality
RECRUITING
Campus Neurológico Sénior, Torres Vedras
WITHDRAWN
University Clinical Center Nis, Niš
WITHDRAWN
Hacettepe University, Ankara
RECRUITING
Istanbul University Istanbul Medical Faculty, Istanbul
WITHDRAWN
Dokuz Eylul University Medical Faculty, Izmir
RECRUITING
Ondokuz Mayis University Hospital, Samsun
COMPLETED
Simbec Orion, Merthyr Tydfil
Lead Sponsor
Collaborators (1)
Takeda
INDUSTRY
Denali Therapeutics Inc.
INDUSTRY